Home  >  Products  >  NPL (N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase) ) Blocking Peptide (the N terminal of NPL)(100ug)
NPL (N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase) ) Blocking Peptide (the N terminal of NPL)(100ug)

NPL (N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase) ) Blocking Peptide (the N terminal of NPL)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-NPL Antibody (ARP63210_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP63210
Size: 100ug
Weight: 25kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: This gene encodes a member of the N-acetylneuraminate lyase sub-family of (beta/alpha)(8)-barrel enzymes. N-acetylneuraminate lyases regulate cellular concentrations of N-acetyl-neuraminic acid (sialic acid) by mediating the reversible conversion of sialic acid into N-acetylmannosamine and pyruvate. A pseudogene of this gene is located on the short arm of chromosome 2. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene.
Alternative names: C1orf13; DHDPS1; MGC149582; MGC61869; NPL1; c112
See Full Product Listings >